Your stress test came back normal. Your cholesterol looks fine. Your doctor smiled, shook your hand, and said you're good. Two years later, you have a heart attack.

That story isn't rare. It's the story of most heart attacks in this country. The standard tests your doctor ran weren't designed to find what's actually killing people: soft plaque growing silently inside your arteries, invisible to every test in a typical checkup.

I'm Dr. Ford Brewer, a preventive medicine physician trained at Johns Hopkins, with over 40 years of clinical experience. I see this exact pattern constantly: a patient gets reassured by normal-looking results, and nobody catches the disease until it's too late. Their wife is counting on them. Their grandkids need them present, not sidelined.

In this article, I'll explain which test can predict up to 98% of heart attacks, why most doctors don't know about it, how I use it with my own patients, and how you can get it so you can finally know whether plaque is quietly building in your arteries right now.

The Mechanism: Why Normal Test Results Don't Mean Safe Arteries

Most people think a normal stress test means their heart is healthy. The real problem is that stress tests only detect flow problems, and flow problems don't show up until you have over 50% blockage. That's severe, late-stage disease.

Here's the chain. Soft plaque begins forming in your artery walls. It's biologically active, filled with inflammatory fluid, unstable, and rupture-prone. Standard screening (stress test, basic cholesterol panel) can't see it. The plaque grows quietly for months or years. One day, the thin cap covering that soft plaque breaks open and touches your blood. A clot forms instantly. If it's large enough and reaches the heart, that's a heart attack. If it reaches the brain, that's a stroke. When the clots are small and microscopic, they keep showering the heart or brain over days, weeks, or years, and you slowly lose function. The tissue starts to look microscopically like Swiss cheese.

The critical insight: plaque that is present but not yet severe enough to restrict blood flow is often the most dangerous stage. At this point, a stress test looks completely normal. Your cholesterol panel may look reasonable. But the disease is already there, active, growing, and potentially lethal.

If you find plaque at this stage and stabilize it, calcify it, calm the biology, the risk drops dramatically. It gets close to what you'd see for someone with no plaque at all¹. That is the opportunity being missed in clinics all over the world, every single day.

1. What the 98% Prediction Actually Means

*Best for: understanding the real predictive power of plaque detection.*

Why It Matters

That number came from a subgroup analysis in a landmark study on carotid plaque. Researchers found that 98% of people with a specific range of plaque, not enough to restrict blood flow but enough to clearly detect on imaging, went on to have cardiovascular events¹.

At the time, researchers didn't fully understand what they were seeing. The key insight came later: plaque present in that range represents the most dangerous window. Detectable but non-obstructive. Active but not yet causing symptoms. That window is where intervention changes everything.

What Most People Miss

This isn't saying that if you have plaque, you will have a heart attack tomorrow. It's saying that detectable, non-obstructive plaque, especially soft plaque, identifies real, actionable risk. And if you can stabilize that plaque before it ruptures, you've changed the outcome entirely. That is a major opportunity that's being missed all over the world.

Question to Ask Your Clinician

"Do I actually have plaque in my arteries, and if so, is it stable or unstable?"

2. Why Your Stress Test Can't Find Early Plaque

*Best for: understanding why "normal" results can be dangerously misleading.*

Why It Matters

A treadmill stress test detects flow problems in the coronary arteries. But here's the problem: in order for a stress test to show something abnormal, you need over 50% blockage. That's not early detection. That's late disease.

So a patient walks in, runs on a treadmill, gets told everything looks fine, and leaves with active plaque building in their arteries that the test was never designed to see. The doctor feels confident. The patient feels reassured. Both are operating on incomplete information.

What Most People Miss

Stress tests are useful for one thing: investigating symptoms. Chest pain, shortness of breath, exercise intolerance, that's when a stress test helps. But as a screening tool for early cardiovascular disease, it misses everything that matters. The same is true for a basic cholesterol panel. Reasonable-looking LDL numbers don't tell you whether plaque is actually forming. Risk calculators like Framingham use age, blood pressure, and cholesterol to estimate risk. But calculators estimate. Plaque shows reality.

The better question is not "how much risk do I have?" The question is: do I already have plaque?

Question to Ask Your Clinician

"Is my stress test actually capable of detecting early plaque, or does it only find severe blockages?"

3. CIMT: The Plaque Stability Test Most Doctors Don't Order

*Best for: detecting soft plaque and tracking whether your prevention plan is working.*

Why It Matters

CIMT stands for Carotid Intima-Media Thickness. It's an ultrasound of the carotid arteries in your neck, and it measures two things: arterial wall thickness and the character of any plaque present, specifically whether that plaque is calcified (stable) or soft (unstable and dangerous).

This is the test behind the 98% prediction. CIMT can detect plaque before it calcifies, at the stage where it's most dangerous and most treatable. Think of CIMT as a plaque stability tool. It doesn't just tell you whether plaque exists. It tells you whether that plaque is biologically active and putting you at risk right now.

CIMT can demonstrate higher risk of heart attack and stroke. It's the test we use all the time in clinical practice.

What Most People Miss

CIMT is not great at measuring exact plaque volume. Patients get confused by this. They see a number change on a repeat CIMT and panic, or feel falsely reassured. That's the wrong use of this test.

Where CIMT shines is detecting plaque presence and tracking whether it's calcifying (stabilizing) or remaining soft (dangerous) over time. One scan is a snapshot. Two scans is a movie. The real power is progression.

Practical Advantages

  • No radiation exposure at all
  • No IV contrast
  • Non-invasive
  • Quick, about 15 to 20 minutes
  • Inexpensive compared to CT angiography

The Downsides

CIMT is operator-dependent. Technique matters. A rushed or sloppy CIMT can under-call or over-call plaque just by changing the angle slightly. That's why patients sometimes come in panicking about a huge increase that isn't real, it's just measurement variability. You want a provider who measures plaque character, not just wall thickness, and one who uses consistent technique so comparisons over time are meaningful.

Question to Ask Your Clinician

"Can I get a CIMT that specifically looks at plaque character, soft versus calcified, not just wall thickness?"

4. Calcium Score: What It Tells You (And What It Misses)

*Best for: understanding why a zero calcium score does not mean zero risk.*

Why It Matters

A coronary calcium score (CAC) measures calcified plaque burden in your coronary arteries. It's easy to get, relatively inexpensive, and widely available. But here's the critical limitation: a calcium score only detects stable, calcified plaque. It completely misses soft plaque, the kind that actually ruptures and causes heart attacks.

Calcified plaque is stable. It does not confer significantly more risk than having no plaque at all. So you have to ask: what exactly is the value of knowing only how much stable plaque you have?

What Most People Miss

Imagine two people the same age. Person one has a calcium score of zero, but soft plaque is building quietly. Person two has a higher calcium score, dense and stable calcified plaque. Which one is safer today?

You cannot answer that question with calcium alone. That's the fundamental problem. A zero calcium score does not mean zero risk. It means no calcified plaque was found, and says nothing about the soft, unstable plaque that kills people.

A calcium score is useful as a general indicator: has this person started the plaque process during their lifetime? But it can't tell you whether you're in danger right now. That's why stability matters in real prevention.

Question to Ask Your Clinician

"My calcium score is [X], but does that tell us anything about soft plaque or my actual risk of a cardiovascular event?"

5. CT Angiography with AI: The Gold Standard (And When You Actually Need It)

*Best for: getting the complete picture of plaque quantity and composition.*

Why It Matters

CTA, coronary CT angiography with AI analysis, is the only test that does both things well: quantifying total plaque burden and characterizing plaque composition. It shows how much plaque is soft, how much is calcified, and gives the most complete picture of what's happening in your coronary arteries. It's the gold standard.

What Most People Miss

CTA uses radioopaque dye, involves radiation exposure, and costs significantly more than either CIMT or a calcium score, often $1,500 to $2,000 or more. For initial assessment when you need the full picture, it's often worth it. But for ongoing monitoring once you know your plaque is stabilizing, repeating a CTA every year doesn't make practical or financial sense.

That's where CIMT takes over as the monitoring tool. Once a CTA has confirmed the plaque is stable, CIMT can track whether it stays stable, without the cost, radiation, or contrast dye.

The Simple Map to Remember

  • Calcium score is better at: quantity of stable plaque. Limitation: misses soft plaque entirely.
  • CIMT is better at: stability assessment and early change detection. Shows soft plaque. Tracks whether plaque is stabilizing or destabilizing over time.
  • CTA with AI can do both together. Limitation: expensive, uses contrast and radiation, not practical for frequent monitoring.

Each test has a place depending on what you're trying to answer.

Question to Ask Your Clinician

"Based on my risk factors, do I need a CTA for initial assessment, and then can we use CIMT to monitor stability going forward?"

6. How This Changes Your Prevention Plan

*Best for: knowing what each CIMT result actually means for your next steps.*

Why It Matters

In practice, CIMT works best as a baseline and a trend tool. Here's how the results translate to real decisions:

If CIMT shows soft plaque: The disease process is active. This doesn't guarantee a heart attack tomorrow, but it means something isn't working in the current prevention plan and you're accumulating real risk. We need a better plan because something's not being caught, and the patient is racking up risk.

If CIMT shows only calcified plaque: The biology is far calmer. That stable plaque went through a period of being unstable before it got there. For the most part, that patient is in a safer place than they were before. The clock still ticks, but the urgency is different.

If CIMT shows no plaque: Reassuring, but it's not a lifetime guarantee. The real power is tracking over time.

What Most People Miss

CIMT tells you where you are on the disease timeline. The goal is not fear. The goal is clarity. And that clarity changes everything about what comes next.

If you remember one thing, remember this: obstruction is late disease. Don't wait for obstruction. Plaque is early disease. That's what you want to know.

Question to Ask Your Clinician

"Can we use CIMT to track whether my plaque is stabilizing over time, and how often should I repeat it?"

What Standard Care Misses (And the Testing That Actually Finds It)

Here's the core problem with standard cardiovascular screening: it's built to find late disease, not early risk. A stress test catches severe blockage. A cholesterol panel estimates particle counts. Neither looks directly at the artery wall. Neither identifies soft plaque. Neither tells you whether active disease is growing right now.

This is a structural limitation of primary care, not a failing of individual physicians. The 7-minute appointment and the standard insurance-reimbursed panel weren't designed for cardiovascular prevention. They were designed for disease management once disease shows up.

The testing that actually catches the problem early:

  • CIMT — direct ultrasound imaging of carotid artery walls. Detects plaque presence and stability. Non-invasive, no radiation, inexpensive. The plaque stability tool.
  • CTA with AI analysis — coronary CT angiography. Quantifies total plaque and characterizes composition. The gold standard for initial assessment.
  • CAC (coronary calcium scoring) — detects calcified plaque burden. Useful as a starting indicator that the plaque process has begun.
  • Lipid fractionation, including ApoB and small-particle LDL (sdLDL) — directly counts the artery-damaging particles. Standard LDL is an estimate.
  • hsCRP, Lp-PLA2, MPO — inflammation markers that predict plaque rupture.
  • OGTT/IR — oral glucose tolerance test with insulin response. Catches the insulin resistance that accelerates plaque formation, which fasting tests miss entirely.

These are the tests that find disease while you can still change the outcome, before obstruction, before symptoms, before the event that changes everything.

The Bottom Line

Obstruction is late disease. Don't wait for obstruction. The plaque that kills people is the plaque nobody found early enough: soft, unstable, invisible to stress tests and standard blood work, but clearly visible on the right imaging.

A practical recap:

  • A normal stress test does NOT mean your arteries are safe. It only catches severe blockages above 50%.
  • Soft plaque is the real danger: unstable, rupture-prone, and invisible to calcium scores.
  • CIMT is a non-invasive, inexpensive ultrasound that detects soft plaque and tracks stability over time.
  • Calcium score shows stable plaque only. A zero score does not mean zero risk.
  • CTA with AI is the gold standard for full plaque assessment, but CIMT is the practical monitoring tool.
  • The 98% prediction applies to detectable, non-obstructive plaque: the stage where intervention can change everything.

The goal isn't fear. The goal is clarity: knowing whether disease is actually present so you can act before it becomes the event that changes your family's life. The people counting on you deserve that certainty, not a reassuring handshake based on the wrong tests.

Growing old is not for sissies. But it's a lot easier with healthy arteries. And if you're 30 or 40, don't wait until you're 68 to figure that out.

Frequently Asked Questions

Quick answers to the questions that come up most often around this topic.

What is the test that predicts 98% of heart attacks?

CIMT, Carotid Intima-Media Thickness. It's an ultrasound of the carotid arteries in your neck that detects plaque presence and characterizes whether that plaque is soft (unstable, dangerous) or calcified (stable, lower risk). A landmark study found that 98% of people with detectable, non-obstructive carotid plaque went on to have cardiovascular events¹. That makes it one of the most powerful predictive tools available, and one most doctors never order.

Why do people with normal stress tests still have heart attacks?

Because stress tests only detect flow problems caused by severe blockages, over 50% obstruction. Soft plaque building in the artery wall, growing and potentially ready to rupture, doesn't restrict flow until it's far too late. A normal stress test means no severe blockage today. It says nothing about whether unstable plaque is already there and progressing quietly.

Is a calcium score of zero really safe?

Not necessarily. A calcium score of zero means no calcified plaque was detected. It says nothing about soft plaque, the biologically active, unstable type that actually ruptures and causes heart attacks. A person can have a zero calcium score while soft plaque is building quietly. That's why stability testing like CIMT matters more than calcium quantity alone.

My doctor said my cholesterol is fine. Should I still worry about plaque?

Yes. Cholesterol numbers estimate risk, but imaging shows reality. A reasonable-looking LDL number doesn't tell you whether plaque is actually forming in your arteries right now. The better question isn't "how much risk do I have?" It's "do I already have plaque, and is it stable?" Ask about direct imaging: CIMT for stability monitoring, or CTA for a complete initial assessment.

What is the difference between soft plaque and calcified plaque?

Soft plaque is biologically active, filled with inflammatory fluid, unstable, and prone to rupture. When it breaks through its thin cap and contacts blood, a clot forms instantly, causing heart attacks and strokes. Calcified plaque is stable, dense, and significantly less dangerous. It does not confer much more risk than having no plaque at all. The goal of prevention is to stabilize soft plaque and calcify it so the biology calms down.

How much does a CIMT test cost?

CIMT typically costs between $100 and $500 depending on your location and provider. It requires no radiation, no IV contrast, and takes about 15 to 20 minutes. Compare that to CTA with AI analysis at $1,500 to $2,000 or more. For ongoing monitoring of plaque stability, CIMT is the practical, repeatable, affordable choice.

How often should I get a CIMT test?

For most patients actively managing cardiovascular risk, repeat CIMT every 12 to 18 months gives meaningful trend data. One scan is a snapshot. Two or more scans over time show whether plaque is progressing, stabilizing, or regressing, which tells you whether your prevention plan is actually working. The specific interval depends on your risk level and what the initial scan shows.

Can you reverse soft plaque once it's been detected?

Yes. If soft plaque is detected early and aggressive prevention is applied, addressing insulin resistance, inflammation, lipid particles, and lifestyle factors, that plaque can stabilize and calcify over time. Once calcified, it's far less dangerous. The risk drops to about what you'd see for someone with no plaque. The key is finding it at the right stage. That's the window most people miss because they never got the imaging.

How PrevMed Helps

If you've had a stress test or cholesterol panel that looked normal, but you've never had anyone actually look at your artery walls, you don't yet know whether disease is present. That's not a criticism of your doctor. It's a structural limitation of what standard screening was built to do.

PrevMed's protocol goes directly to the question that matters: do you have plaque, and if so, is it stable? The testing includes CIMT for plaque stability monitoring, CTA with AI analysis for comprehensive plaque assessment, ApoB and lipid fractionation for particle-level risk, hsCRP and inflammatory markers for rupture prediction, and OGTT/IR for the insulin resistance that accelerates plaque formation.

The people counting on you, your wife, your grandkids, your community, deserve better than a reassuring handshake based on tests that weren't designed to find what's actually there. If you want to know where you actually stand, start with the PrevMed Heart Attack Prevention Assessment. It's the first step toward knowing whether plaque is building silently and what to do about it while you still can.

References

  • Defined by Bots ML, Pignoli P, et al. "Carotid and femoral ultrasound morphology screening and cardiovascular events in low risk subjects: a 10-year follow-up study (the CAFES-CAVE study)." Atherosclerosis. 2001;156(2):379–387. DOI: 10.1016/S0021-9150(00)00665-1. PubMed ID: 11395035. A 10-year prospective study of 13,221 low-risk, healthy, asymptomatic individuals classified by carotid and femoral bifurcation ultrasound morphology. The 98% figure refers to the subgroup with Class III findings (non-stenosing plaques): detectable plaque not yet severe enough to restrict blood flow, which went on to experience cardiovascular events at that rate.

Additional reading

This article is for educational purposes and isn’t medical advice. Talk to a clinician about decisions specific to your health.